Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Millan

Showing results (221-230 of 496) with videos related to

Pageof 50
Sort By:
Neuropharmacology|November 2, 2010
Differential induction of adenylyl cyclase supersensitivity by antiparkinson drugs acting as agonists at dopamine D1/D2/D3 receptors vs D2/D3 receptors only: parallel observations from co-transfected human and native cerebral receptorsGabriella Aloisi, Elena Silvano, Mario Rossi, et al.
Psychopharmacology|October 21, 2000
The selective serotonin (5-HT)1A receptor ligand, S15535, displays anxiolytic-like effects in the social interaction and Vogel models and suppresses dialysate levels of 5-HT in the dorsal hippocampus of freely-moving rats. A comparison with other anxiolytic agentsA Dekeyne, M Brocco, A Adhumeau, et al.
Journal of Neurochemistry|March 1, 1997
Buspirone enhances duloxetine- and fluoxetine-induced increases in dialysate levels of dopamine and noradrenaline, but not serotonin, in the frontal cortex of freely moving ratsA Gobert, J M Rivet, J M Cistarelli, et al.
European Journal of Pharmacology|January 29, 1997
Noradrenaline and adrenaline are high affinity agonists at dopamine D4 receptorsA Newman-Tancredi, V Audinot-Bouchez, A Gobert, et al.
Psychopharmacology|February 27, 2004
The role of dopamine D3 compared with D2 receptors in the control of locomotor activity: a combined behavioural and neurochemical analysis with novel, selective antagonists in ratsMark J Millan, Laetitia Seguin, Alain Gobert, et al.
European Journal of Pharmacology|April 17, 2004
The novel monoamine reuptake inhibitor and potential antidepressant, S33005, induces Arc gene expression in cerebral cortexQi Pei, Marie Sprakes, Mark J Millan, et al.
The Journal of Pain|November 19, 2003
Electrophysiologic characterization of the antinociceptive actions of S18616, a novel and potent alpha 2-adrenoceptor agonist, after acute and persistent pain statesRie Suzuki, G Mark Green, Mark J Millan, et al.
Pharmacology, Biochemistry, and Behavior|March 13, 2002
Induction of hyperlocomotion in mice exposed to a novel environment by inhibition of serotonin reuptake. A pharmacological characterization of diverse classes of antidepressant agentsMauricette Brocco, Anne Dekeyne, Sylvie Veiga, et al.
Brain Research|July 28, 1987
A model of chronic pain in the rat: high-resolution neuroanatomical approach identifies alterations in multiple opioid systems in the periaqueductal greyM J Millan, B J Morris, F C Colpaert, et al.
Psychopharmacology|June 29, 2005
Acute administration of the novel serotonin and noradrenaline reuptake inhibitor, S33005, markedly modifies sleep-wake cycle architecture in the ratRaymond Cespuglio, Colette Rousset, Gabriel Debilly, et al.
Pageof 50

Showing results (221-230 of 496) with videos related to

Sort By:
Pageof 50
Neuropharmacology|November 2, 2010
Differential induction of adenylyl cyclase supersensitivity by antiparkinson drugs acting as agonists at dopamine D1/D2/D3 receptors vs D2/D3 receptors only: parallel observations from co-transfected human and native cerebral receptorsGabriella Aloisi, Elena Silvano, Mario Rossi, et al.
Psychopharmacology|October 21, 2000
The selective serotonin (5-HT)1A receptor ligand, S15535, displays anxiolytic-like effects in the social interaction and Vogel models and suppresses dialysate levels of 5-HT in the dorsal hippocampus of freely-moving rats. A comparison with other anxiolytic agentsA Dekeyne, M Brocco, A Adhumeau, et al.
Journal of Neurochemistry|March 1, 1997
Buspirone enhances duloxetine- and fluoxetine-induced increases in dialysate levels of dopamine and noradrenaline, but not serotonin, in the frontal cortex of freely moving ratsA Gobert, J M Rivet, J M Cistarelli, et al.
European Journal of Pharmacology|January 29, 1997
Noradrenaline and adrenaline are high affinity agonists at dopamine D4 receptorsA Newman-Tancredi, V Audinot-Bouchez, A Gobert, et al.
Psychopharmacology|February 27, 2004
The role of dopamine D3 compared with D2 receptors in the control of locomotor activity: a combined behavioural and neurochemical analysis with novel, selective antagonists in ratsMark J Millan, Laetitia Seguin, Alain Gobert, et al.
European Journal of Pharmacology|April 17, 2004
The novel monoamine reuptake inhibitor and potential antidepressant, S33005, induces Arc gene expression in cerebral cortexQi Pei, Marie Sprakes, Mark J Millan, et al.
The Journal of Pain|November 19, 2003
Electrophysiologic characterization of the antinociceptive actions of S18616, a novel and potent alpha 2-adrenoceptor agonist, after acute and persistent pain statesRie Suzuki, G Mark Green, Mark J Millan, et al.
Pharmacology, Biochemistry, and Behavior|March 13, 2002
Induction of hyperlocomotion in mice exposed to a novel environment by inhibition of serotonin reuptake. A pharmacological characterization of diverse classes of antidepressant agentsMauricette Brocco, Anne Dekeyne, Sylvie Veiga, et al.
Brain Research|July 28, 1987
A model of chronic pain in the rat: high-resolution neuroanatomical approach identifies alterations in multiple opioid systems in the periaqueductal greyM J Millan, B J Morris, F C Colpaert, et al.
Psychopharmacology|June 29, 2005
Acute administration of the novel serotonin and noradrenaline reuptake inhibitor, S33005, markedly modifies sleep-wake cycle architecture in the ratRaymond Cespuglio, Colette Rousset, Gabriel Debilly, et al.
Pageof 50